New patient-focused five minute Herceptin® (trastuzumab) jab given green light by reg

[News]

Patients with a very aggressive form of breast cancer known as HER2-positive, could now benefit from a new faster, more efficient delivery method of Herceptin. The subcutaneous (SC) injection, given just beneath the skin, can be completed in 2-5 minutes, compared to the traditional, relatively time-consuming 30-90 minute intravenous (IV) infusion...

More... (http://www.medicalnewstoday.com/releases/266530.php)